Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/11095
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | restrictedAccess | - |
dc.contributor.author | Pejović, Anka | - |
dc.contributor.author | Drabowicz, Jozef | - |
dc.contributor.author | Cieślak M. | - |
dc.contributor.author | Kazmierczak-Barańska J. | - |
dc.contributor.author | Krolewska-Golinska K. | - |
dc.date.accessioned | 2021-04-20T17:29:18Z | - |
dc.date.available | 2021-04-20T17:29:18Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0022-328X | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/11095 | - |
dc.description.abstract | © 2018 Elsevier B.V. A two new series of ferrocene containing quinolinones – 1-allyl-2-ferrocenyl-2,3-dihydroquinolin-4(1H)-ones and 1-allyl-2-ferrocenylquinolin-4(1H)-ones – were prepared and characterized by standard spectroscopic techniques and cyclic voltammetry. The in vitro antitumor activity of all synthesized compounds was investigated against Human Cervix Carcinoma (HeLa), Chronic Myelogenous Leukemia (K562) and normal endothelial (HUVEC) cell lines using the MTT method. Quinolone derivative 5c exhibited the highest cytotoxic activity in the cell growth inhibition of HeLa cell line while 5f was the most toxic against K562 cells. | - |
dc.rights | info:eu-repo/semantics/restrictedAccess | - |
dc.source | Journal of Organometallic Chemistry | - |
dc.title | Synthesis, characterization and anticancer activity of novel ferrocene containing quinolinones: 1-Allyl-2-ferrocenyl-2,3-dihydroquinolin-4(1H)-ones and 1-allyl-2-ferrocenylquinolin-4(1H)-ones | - |
dc.type | article | - |
dc.identifier.doi | 10.1016/j.jorganchem.2018.08.004 | - |
dc.identifier.scopus | 2-s2.0-85051679959 | - |
Appears in Collections: | Faculty of Science, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PaperMissing.pdf Restricted Access | 29.86 kB | Adobe PDF | ![]() View/Open |
Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.